Rs2 Payer Roadblocks to Risk-Sharing Agreements Around the World: Where, When and How?

Andò, Giuseppe; Kowal, Stacey; Reinaud, F.

doi:10.1016/s1098-3015(11)71855-1

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…I identify a number of problems with the OFT proposals. I recommend that key elements of a reformed UK pharmaceutical environment for 2010 should include an expanded role for HTA but with companies retaining freedom to set prices at launch; HTA use targeted via a contingent value-of-information approach; a retained backstop PPRS, perhaps moving to an RPI-X type control; the use of RSAs and non-linear pricing arrangements; measures to ensure more effective therapeutic switching at local level; and measures to improve the take up of cost-effective treatments Ando et al [ 73 ] The increasing use of risk-sharing in reimbursement decisions across major markets necessitates that key stakeholders understand the role of this concept in shaping drug development and regulatory decision making. The objective of this research was to examine global trends in RSAs since 1990 to provide a comprehensive understanding of the current and future impact of this fast-evolving concept.…”

Section: Resultsmentioning

confidence: 99%

Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends

Piatkiewicz

Traulsen

Holm-Larsen

2017

PharmacoEconomics Open

View full text Add to dashboard Cite

ObjectiveOur objectives were to explore the changes in the level of interest in risk-sharing agreements (RSAs) in the EU during the last 15 years and the underlying reasons for these changes.MethodsA systematic literature review was conducted using PubMed, Scopus, Web of Science, and Embase. Articles identified were divided into ‘quantitative articles’ used to establish the level of interest and ‘qualitative articles’ used to identify the underlying trends in RSAs.ResultsThe literature search retrieved 2144 scientific articles. Data were extracted from 238 articles. Of these, 100 contained quantitative data and 138 contained qualitative data. The pace of articles being published about RSAs grew significantly in 2015, which related to the increase in interest in and knowledge about RSAs. The underlying reasons for the fluctuations were condensed into four overall themes: (1) push for value-based pricing, (2) economic crisis and further push to contain costs, (3) criticism of RSAs in the real world, and (4) diversification of RSAs to fit the purpose.ConclusionThe overall level of interest in RSAs in the EU has been increasing since 2000; therefore, articles reporting the number of RSAs implemented and case studies have been steadily growing as evidence is becoming more readily available. The number of qualitative articles reporting and discussing the underlying reasons for these changes in interest has largely fluctuated over the last 15 years. Despite these fluctuations, interest in RSAs remains high.Electronic supplementary materialThe online version of this article (doi:10.1007/s41669-017-0044-1) contains supplementary material, which is available to authorized users.

show abstract